BASTA JAMES 4
4 · Intellia Therapeutics, Inc. · Filed Mar 4, 2025
Insider Transaction Report
Form 4
BASTA JAMES
EVP, General Counsel
Transactions
- Sale
Common Stock
2025-03-04$8.99/sh−2,572$23,122→ 111,925 total - Award
Common Stock
2025-03-01+40,000→ 114,497 total - Award
Stock Option (right to buy)
2025-03-01+57,143→ 57,143 totalExercise: $10.09Exp: 2035-02-28→ Common Stock (57,143 underlying)
Footnotes (3)
- [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit
- [F2]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on March 1, 2025, and does not represent a volitional trade by the Reporting Person.
- [F3]This option was granted on March 1, 2025 with respect to shares of Common Stock, with 33% vesting on January 1, 2026 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.